30 percent of all health care spending in the United States is on low-value or unnecessary care—wasting billions and harming consumers.
A recent analysis of CMS data indicates that, while non-white beneficiaries are increasingly choosing Medicare Advantage, MA plans significantly under report for non-white racial/ethnic groups on HEDIS and CAHPS measures.
If the constant price hikes of high-priced specialty drugs are left unchecked, prescription drug costs will continue to explode.
The ongoing COVID-19 public health crisis is causing an unprecedented shift in theRead more
ACHP member health plans run fully transparent, fee-based PBMs that keep drug costs in check.
Kaiser Permanente implemented safer opioid prescribing practices in 2012 and has greatly reduced opioid prescribing across all regions.
Working together, Intermountain Healthcare and SelectHealth were able to eliminate medically-unnecessary early inductions.
Millions struggle to pay high drug prices, forcing them to choose either medication or other expenses. Our infographic explains how “biosimilars” can help.
Making Health Care Better
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.